| Exosome-mediated metastasis: from epithelial–mesenchymal transition to escape from immunosurveillance N Syn, L Wang, G Sethi, JP Thiery, BC Goh Trends in pharmacological sciences 37 (7), 606-617, 2016 | 518 | 2016 |
| Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges NL Syn, L Wang, EKH Chow, CT Lim, BC Goh Trends in biotechnology 35 (7), 665-676, 2017 | 409 | 2017 |
| Phenolic compounds of Chromolaena odorata protect cultured skin cells from oxidative damage: implication for cutaneous wound healing TT Phan, L Wang, P See, RJ Grayer, SY Chan, ST Lee Biological and Pharmaceutical Bulletin 24 (12), 1373-1379, 2001 | 356 | 2001 |
| Resveratrol for cancer therapy: Challenges and future perspectives B Ren, MXY Kwah, C Liu, Z Ma, MK Shanmugam, L Ding, X Xiang, ... Cancer letters 515, 63-72, 2021 | 318 | 2021 |
| Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies BC Goh, SC Lee, LZ Wang, L Fan, JY Guo, J Lamba, E Schuetz, R Lim, ... Journal of clinical oncology 20 (17), 3683-3690, 2002 | 317 | 2002 |
| Targeting transcription factor STAT3 for cancer prevention and therapy EZP Chai, MK Shanmugam, F Arfuso, A Dharmarajan, C Wang, AP Kumar, ... Pharmacology & therapeutics 162, 86-97, 2016 | 287 | 2016 |
| Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer TZ Tan, QH Miow, RYJ Huang, MK Wong, J Ye, JA Lau, MC Wu, ... EMBO molecular medicine 5 (7), 1051-1066, 2013 | 235 | 2013 |
| Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of … W Yeo, HC Chung, SL Chan, LZ Wang, R Lim, J Picus, M Boyer, FKF Mo, ... Journal of Clinical Oncology 30 (27), 3361-3367, 2012 | 212 | 2012 |
| Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies AL Wong, RA Soo, DS Tan, SC Lee, JS Lim, PC Marban, LR Kong, ... Annals of Oncology 26 (5), 998-1005, 2015 | 197 | 2015 |
| A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer … B Ma, BC Goh, EH Tan, KC Lam, R Soo, SS Leong, LZ Wang, F Mo, ... Investigational new drugs 26, 169-173, 2008 | 196 | 2008 |
| A warfarin‐dosing model in Asians that uses single‐nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9 LS Tham, BC Goh, A Nafziger, JY Guo, LZ Wang, R Soong, SC Lee Clinical Pharmacology & Therapeutics 80 (4), 346-355, 2006 | 191 | 2006 |
| Garcinol: Current status of its anti-oxidative, anti-inflammatory and anti-cancer effects C Liu, PCL Ho, FC Wong, G Sethi, LZ Wang, BC Goh Cancer letters 362 (1), 8-14, 2015 | 179 | 2015 |
| Insights into biological role of LncRNAs in epithelial-mesenchymal transition JT Cheng, L Wang, H Wang, FR Tang, WQ Cai, G Sethi, HW Xin, Z Ma Cells 8 (10), 1178, 2019 | 178 | 2019 |
| Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL Q Wen, B Goldenson, SJ Silver, M Schenone, V Dancik, Z Huang, ... Cell 150 (3), 575-589, 2012 | 167 | 2012 |
| Nimbolide-induced oxidative stress abrogates STAT3 signaling cascade and inhibits tumor growth in transgenic adenocarcinoma of mouse prostate model J Zhang, KS Ahn, C Kim, MK Shanmugam, KS Siveen, F Arfuso, ... Antioxidants & redox signaling 24 (11), 575-589, 2016 | 159 | 2016 |
| Therapeutic potential of gambogic acid, a caged xanthone, to target cancer K Banik, C Harsha, D Bordoloi, BL Sailo, G Sethi, HC Leong, F Arfuso, ... Cancer letters 416, 75-86, 2018 | 148 | 2018 |
| Potential role of genipin in cancer therapy MK Shanmugam, H Shen, FR Tang, F Arfuso, M Rajesh, L Wang, ... Pharmacological research 133, 195-200, 2018 | 129 | 2018 |
| Targeting metabolism in cancer cells and the tumour microenvironment for cancer therapy J Li, JQ Eu, LR Kong, L Wang, YC Lim, BC Goh, ALA Wong Molecules 25 (20), 4831, 2020 | 128 | 2020 |
| Role of novel histone modifications in cancer MK Shanmugam, F Arfuso, S Arumugam, A Chinnathambi, B Jinsong, ... Oncotarget 9 (13), 11414, 2017 | 126 | 2017 |
| Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds Z Ma, X Xiang, S Li, P Xie, Q Gong, BC Goh, L Wang Seminars in cancer biology 80, 379-390, 2022 | 124 | 2022 |
